The use of prostate-specific antigen (PSA) testing for prostate cancer screening remains the subject of scientific debate. Experts are unable to agree on how to balance the benefit of such testing ...
Reduction in prostate cancer-specific mortality corresponds to two fewer deaths per 1,000/ (HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results